Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06810544
What this trial is testing

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Who this might be right for
Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more
Tango Therapeutics, Inc. 191
Early research (Phase 1)Ended earlyNCT02707666
What this trial is testing

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
University of Chicago 7
Early research (Phase 1)Ended earlyNCT04836429
What this trial is testing

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

Who this might be right for
Lung Non-Small Cell CarcinomaPleural Disorder
Roswell Park Cancer Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 140
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT03213301
What this trial is testing

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Swiss Cancer Institute 42
Not applicableNot Yet RecruitingNCT06775587
What this trial is testing

SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules

Who this might be right for
Lung Cancer in Normal and Malignant Tumors
Fuzhou General Hospital 200
Early research (Phase 1)Looking for participantsNCT06375187
What this trial is testing

GC203 TIL in Advanced Malignant Solid Tumors

Who this might be right for
Solid TumorGynecologic CancerBreast Cancer+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)Ended earlyNCT02920996
What this trial is testing

Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSolid Tumor
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Ended earlyNCT00895648
What this trial is testing

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
University Health Network, Toronto 6
Not applicableActive Not RecruitingNCT05731076
What this trial is testing

Self-Management Support for Lung Cancer Patients With Cachexia

Who this might be right for
Cachexia-Anorexia SyndromeLung Neoplasm Malignant
Changhua Christian Hospital 104
Not applicableStudy completedNCT06581549
What this trial is testing

Immune Microenvironment and Gene Expression Profiling in Mesothelioma

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma; Lung
Istituto Oncologico Veneto IRCCS 125
Not applicableNot Yet RecruitingNCT07550049
What this trial is testing

Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology

Who this might be right for
Small Cell Lung CancerHead and Neck CancerMalignant Pleural Mesothelioma
University of Kansas Medical Center 110
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableUnknownNCT03558932
What this trial is testing

IP3R Modulation by Cancer Genes in Mesothelioma

Who this might be right for
Malignant Mesothelioma
KU Leuven 20
Not applicableUnknownNCT04182893
What this trial is testing

Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules

Who this might be right for
Pulmonary Nodules
Shanghai Chest Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT05180474
What this trial is testing

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Who this might be right for
Breast Cancer, Breast NeoplasmsEndometrial Cancer, Endometrial NeoplasmOvarian Cancer, Ovarian Neoplasms+1 more
Genmab 179
Not applicableLooking for participantsNCT07315347
What this trial is testing

Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.

Who this might be right for
Active Cancer and Symptomatic or Incidental Pulmonary Embolism Without HESTIA Criteria
Assistance Publique - Hôpitaux de Paris 824
Next Page